<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05117671</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00133; mu21Clauss</org_study_id>
    <nct_id>NCT05117671</nct_id>
  </id_info>
  <brief_title>Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?</brief_title>
  <official_title>Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice? - a Multicentric Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective multi-center, multi-national cohort study is to validate the European Bone&#xD;
      and Joint Infection Society (EBJIS) Definition of Prosthetic Joint Infection. Specifically,&#xD;
      it is to analyze the outcome of the Infection Likely group and compare it to the Infection&#xD;
      Unlikely group as well as other subgroups within previous validated definitions&#xD;
      (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal&#xD;
      Infection (ICM) 2013 and ICM 2018).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periprosthetic joint infection (PJI) is a major burden for healthcare systems. The European&#xD;
      Bone and Joint Infection Society (EBJIS) proposed a new set of criteria introducing a three&#xD;
      level 'traffic light' distinction: Infection Unlikely, Infection Confirmed but also an&#xD;
      intermediate group called Infection Likely (but nor confirmed). This retrospective&#xD;
      multi-center, multi-national cohort study is to validate the EBJIS Definition of Prosthetic&#xD;
      Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and&#xD;
      compare it to the Infection Unlikely group as well as other subgroups within previous&#xD;
      validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on&#xD;
      Musculoskeletal Infection (ICM) 2013 and ICM 2018).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prosthetic Joint Infections (with or without the need for further surgery)</measure>
    <time_frame>since 01.01.2013 with a minimum of two years follow up</time_frame>
    <description>Number of Prosthetic Joint Infections (with or without the need for further surgery) among each PJI definition (&quot;Infection Unlikely&quot;, &quot;Infection Confirmed&quot;, &quot;Infection Likely (but nor confirmed)&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prosthetic Joint Infections (with or without the need for further surgery)</measure>
    <time_frame>since 01.01.2013 with a minimum of two years follow up</time_frame>
    <description>Number of Prosthetic Joint Infections (with or without the need for further surgery) according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for Revision Surgery</measure>
    <time_frame>since 01.01.2013 with a minimum of two years follow up</time_frame>
    <description>Number of Revision Surgeries (for all causes, PJI and aseptic failure) among each PJI definition (&quot;Infection Unlikely&quot;, &quot;Infection Confirmed&quot;, &quot;Infection Likely (but nor confirmed)&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Need for Revision Surgery</measure>
    <time_frame>since 01.01.2013 with a minimum of two years follow up</time_frame>
    <description>Number of Revision Surgeries (for all causes, PJI and aseptic failure) according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival rates of different subgroups among each PJI definition</measure>
    <time_frame>since 01.01.2013 with a minimum of two years follow up</time_frame>
    <description>Survival rates of different subgroups among each PJI definition (&quot;Infection Unlikely&quot;, &quot;Infection Confirmed&quot;, &quot;Infection Likely (but nor confirmed)&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival rates between different definitions</measure>
    <time_frame>since 01.01.2013 with a minimum of two years follow up</time_frame>
    <description>Survival rates between different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Periprosthetic Joint Infection (PJI)</condition>
  <arm_group>
    <arm_group_label>revision total hip or knee arthroplasties</arm_group_label>
    <description>THA/TKA patients that underwent revision surgery between 01.01.2013 until 31.12.2018</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>data collection to classify infection status</intervention_name>
    <description>Review of medical records of all selected cases (TKA/THA patients) to classify infection status according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).</description>
    <arm_group_label>revision total hip or knee arthroplasties</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        THA/TKA patients that underwent revision surgery regardless of final aseptic vs. infected&#xD;
        diagnosis between 1st of January 2013 until 31.12.2018. All data coming from everyday&#xD;
        clinical work. The average patient operated with revision arthroplasty is normally aged&#xD;
        above 70 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  THA/TKA patients that underwent revision surgery regardless of final aseptic vs.&#xD;
             infected diagnosis between 01.01.2013 until 31.12.2018&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  less than two years follow up&#xD;
&#xD;
          -  less than four intraoperative microbiology samples (synovial fluid, tissue samples,&#xD;
             implant sonication)&#xD;
&#xD;
          -  no preoperative/intraoperative synovial fluid differential leukocyte count&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Jorge Gomes de Sousa, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro Hospitalar Universitario do Porto, Orthopedics Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Clauss, PD Dr. med.</last_name>
    <phone>+41 61 328 6007</phone>
    <email>Martin.clauss@usb.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto, Porto, Portugal</name>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Jorge Gomes de Sousa, Prof. Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Ricardo Jorge Gomes de Sousa, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel, Orthopedics and Traumatology</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Clauss, PD Dr. med.</last_name>
      <phone>+41 61 328 6007</phone>
      <email>Martin.clauss@usb.ch</email>
    </contact>
    <investigator>
      <last_name>Martin Clauss, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Portugal</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 10, 2021</study_first_submitted>
  <study_first_submitted_qc>November 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infection Likely group</keyword>
  <keyword>Infection Unlikely group</keyword>
  <keyword>European Bone and Joint Infection Society (EBJIS)</keyword>
  <keyword>revision total hip arthroplasty (THA)</keyword>
  <keyword>revision total knee arthroplasty (TKA)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Arthritis, Infectious</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

